menu
    • menu

    Company profile for Celltrion

    NEW Drugs in Dev: 41
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celltrion stands as a prominent player in the Korean pharmaceutical landscape, accomplishing a feat once deemed improbable introducing the world's first "antibody biosimilar" from a nation with a comparatively less developed pharmaceutical sector. The company has boldly ventured into unexplored territories, achieving remarkable success. Building on this momentum, Celltrion is poised to further expand its footprint as a global ...
    Celltrion stands as a prominent player in the Korean pharmaceutical landscape, accomplishing a feat once deemed improbable introducing the world's first "antibody biosimilar" from a nation with a comparatively less developed pharmaceutical sector. The company has boldly ventured into unexplored territories, achieving remarkable success. Building on this momentum, Celltrion is poised to further expand its footprint as a global biopharmaceutical entity, showcasing distinctive strategies in areas like small molecule pharmaceuticals and pioneering ventures such as the Ubiquitous healthcare platform business.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Celltrionkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Yeonsu-gu, Incheon Metropolitan City
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.celltrion.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/celltrioninc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/celltriondream?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Celltrion Unveils Pipeline, US R&D Expansion at JPM Conference
    Celltrion Unveils Pipeline, US R&D Expansion at JPM Conference

    13 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/celltrion-presents-innovative-drug-pipeline-and-us-manufacturing-and-rd-expansion-strategy-at-the-44th-annual-jp-morgan-healthcare-conference-302660477.html

    PR NEWSWIRE
    13 Jan 2026
    Share Share
    Celltrion To Present At 44th J.P. Morgan Healthcare Conference
    Celltrion To Present At 44th J.P. Morgan Healthcare Conference

    06 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/celltrion-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302654432.html

    PR NEWSWIRE
    06 Jan 2026
    Share Share
    Celltrion's Steqeyma Autoinjector Gets Positive CHMP Opinion
    Celltrion's Steqeyma Autoinjector Gets Positive CHMP Opinion

    18 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-18/celltrion-receives-positive-chmp-opinion-for-steqeyma-ustekinumab-biosimilar-autoinjector-1

    PHARMIWEB
    18 Dec 2025
    Share Share
    Abpro Holdings Submits IND For Phase 1 Trial Of T Cell Engager
    Abpro Holdings Submits IND For Phase 1 Trial Of T Cell Engager

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205290/0/en/Abpro-Holdings-Announces-Submission-of-an-IND-Application-to-Initiate-a-Phase-1-Clinical-Trial-of-T-cell-engager-ABP-102-CT-P72-for-HER2-positive-Cancers.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Celltrion Launches Fda-Approved 300Mg OMLYCLO Biosimilar
    Celltrion Launches Fda-Approved 300Mg OMLYCLO Biosimilar

    02 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/celltrion-announces-us-fda-approval-of-300mg-strength-of-omlyclo-omalizumab-igec-the-first-and-only-fda-approved-interchangeable-biosimilar-to-xolair-302631123.html

    PR NEWSWIRE
    02 Dec 2025
    Share Share
    Celltrion receives Canada approval for Eydenzelt
    Celltrion receives Canada approval for Eydenzelt

    27 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251119058907/en/Celltrion-receives-Health-Canada-approval-for-Eydenzelt-a-biosimilar-referencing-Eylea-aflibercept-2mg

    BUSINESSWIRE
    27 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Contact Celltrion and get a quotation

    Celltrion is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of Infliximab bulk with JDMF offered by Celltrion

    Find a price of Trastuzumab bulk with JDMF offered by Celltrion

    Find a price of Infliximab bulk offered by Celltrion

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search